Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 87
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.01-076 - TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC

      09:30 - 09:30  |  Author(s): R. Camidge

      • Abstract

      Loading...

    • +

      P1.01-084 - A Phase 2 Study of TH-4000 in Patients with EGFR Mutant, T790M-Negative, Advanced NSCLC Progressing on an EGFR TKI

      09:30 - 09:30  |  Author(s): S.V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 01 - Chemotherapy Developments for Lung Cancer

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 7
    • Moderators:G. Blumenschein
    • Coordinates: 9/07/2015, 10:45 - 12:15, 401-404
    • +

      ORAL01.02 - Therapy of Advanced Metastatic Lung Cancers with an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132: Interim Phase II Clinical Results

      10:56 - 11:07  |  Author(s): R. Camidge

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 02 - PD1 Axis Immunotherapy 2

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:E.B. Garon
    • Coordinates: 9/07/2015, 10:45 - 12:15, Four Seasons Ballroom F1+F2
    • +

      ORAL02.07 - Atezolizumab (MPDL3280A) Combined with Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): A Phase Ib Safety and Efficacy Update

      11:50 - 12:01  |  Author(s): R. Camidge

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 03 - PD1 Axis Inhibition and EGFR

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 11
    • Moderators:L. Gandhi
    • Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F1+F2
  • +

    MINI 04 - Clinical Care of Lung Cancer

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:L. Gaspar
    • Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2c-3c
    • +

      MINI04.08 - Malignant Pleural Effusions Are Predictive of Peritoneal Carcinomatosis in Patients with Advanced EGFR Positive Non-Small Cell Lung Cancer

      17:25 - 17:30  |  Author(s): T. Patil

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 102
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.01-090 - A Phase 2, Single Arm Study of Lucitanib in Patients with Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF-Related Genetic Changes

      09:30 - 09:30  |  Author(s): D.R. Spigel

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 13 - Genetic Alterations and Testing

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 15
    • Moderators:Y. Koh
    • Coordinates: 9/08/2015, 10:45 - 12:15, 205+207
  • +

    MINI 16 - EGFR Mutant Lung Cancer 2

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:G.J. Riely
    • Coordinates: 9/08/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
  • +

    MINI 21 - Novel Targets

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 13
    • Moderators:B.P. Levy
    • Coordinates: 9/08/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
  • +

    ED 11 - Extending Personalized Treatment Beyond EGFR

    • Type: Education Session
    • Track: Community Practice
    • Presentations: 5
    • Moderators:R. Perez-Soler
    • Coordinates: 9/09/2015, 14:15 - 15:45, 401-404
    • +

      Introduction

      14:15 - 14:20

      • Abstract

      No abstract available for this presentation

    • +

      ED11.01 - What Testing Is Needed for Clinical Treatment?

      14:20 - 14:40  |  Author(s): P.A. Bunn, Jr

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ED11.02 - Communicating with Pathologists About Molecular Testing

      14:40 - 15:00  |  Author(s): C.O. Lara-Torres

      • Abstract
      • Presentation

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ED11.03 - 1st Line and Beyond for ALK, ROS-1, BRAF, RET, FGFR Positive Lung Cancer

      15:00 - 15:20  |  Author(s): D.R. Spigel

      • Abstract

      Loading...

    • +

      ED11.04 - Prioritizing New Agents When More than One Is Available and Combining Targeted Agents

      15:20 - 15:40  |  Author(s): R. Camidge

      • Abstract
      • Presentation

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.